SLC25A39P2

Across TCGA pan-cancer cohorts, SLC25A39P2 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SLC25A39P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SLC25A39P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC25A39P2 expression acts as an unfavorable survival marker.

KIRC, UCS, and UCEC are the cancer types where SLC25A39P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.496	0.657	<.001	138	view →
UCS	OS	Tertile	All	0.001	0.690	<.001	108	view →
UCEC	OS	Tertile	II,III,IV	0.586	0.804	<.001	84	view →
LUSC	DFS	Tertile	All	0.603	0.768	.003	54	view →
THCA	DFS	Tertile	III,IV	0.383	0.739	.003	48	view →
LIHC	DFS	Tertile	All	0.205	0.538	.008	48	view →
ACC	OS	Tertile	All	0.133	0.686	.004	45	view →
OV	OS	Tertile	III,IV	0.362	0.687	.002	30	view →
BLCA	OS	Tertile	IV	0.111	0.590	<.001	18	view →
PCPG	OS	Tertile	All	0.438	0.968	.004	18	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
PAAD	DFS	Tertile	II,III,IV	0.355	0.451	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SLC25A39P2–KIRC (DFS)

Open the KIRC breakdown →